Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheppeck, R. A.
Right arrow Articles by Johnson, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheppeck, R. A.
Right arrow Articles by Johnson, P. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Examination of the roles of glycoprotein Ib and glycoprotein IIb/IIIa in platelet deposition on an artificial surface using clinical antiplatelet agents and monoclonal antibody blockade

RA Sheppeck, M Bentz, C Dickson, S Hribar, J White, J Janosky, SA Berceli, HS Borovetz and PC Johnson

Department of Surgery, University of Pittsburgh School of Medicine, PA.

The mechanism of platelet thrombus growth on an artificial surface is incompletely understood. While glycoprotein (GP)Ib and GPIIb/IIIa are required for normal attachment and thrombus formation on subendothelium, their roles in platelet deposition to artificial surfaces remain unclear. Using selected platelet inhibitors (aspirin [ASA], low molecular weight dextran, monoclonal antibodies 10E5 [v GPIIb/IIIa], and 6D1 [GPIb]) we examined the mechanism of platelet deposition to polyethylene (PE) surfaces under steady laminar and oscillatory flow conditions. Polyethylene-100 (PE-100) tubes (0.86 mm internal diameter) were perfused under steady laminar flow with citrated human whole blood reconstituted with 111indium-labeled platelets at 312 seconds-1 shear rate in the presence and absence of platelet inhibitors. The effect of oscillatory flow on platelet deposition was examined in a microwell system using 3/16-inch diameter discs of National Heart, Lung, and Blood Institute primary reference PE as the test surface. ASA and dextran did not significantly (P greater than .05) inhibit platelet deposition in laminar flow (not tested in oscillatory). Antibody 10E5 was a potent inhibitor (laminar less than 1%, P less than .0001, oscillatory less than 1.6%, P less than .01) of platelet deposition in both systems, and in this case, true adhesion (first attached layer) was blocked. Antibody 6D1 unexpectedly inhibited 70% of platelet deposition (P less than .01) in steady laminar flow and 56.5% in oscillatory flow (P less than .01). Scanning electron microscopy demonstrated platelets atop platelets in the controls, rare platelets in the 10E5 group, and a patchy monolayer of platelets in the 6D1 group. Transmission electron microscopy of cross-sections confirmed these observations. We conclude that the adhesion of the first platelet layer to an artificial surface requires GPIIb/IIIa. The data also suggest that GPIb is required for the development of the second layer in vertical platelet thrombus growth.

Volume 78, Issue 3, pp. 673-680, 08/01/1991
Copyright © 1991 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PerfusionHome page
F D Rubens and T Mesana
The inflammatory response to cardiopulmonary bypass: a therapeutic overview
Perfusion, January 1, 2004; 19(1_suppl): S5 - S12.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
Y. Niimi, F. Ichinose, Y. Ishiguro, K. Terui, S. Uezono, S. Morita, and S. Yamane
The Effects of Heparin Coating of Oxygenator Fibers on Platelet Adhesion and Protein Adsorption
Anesth. Analg., September 1, 1999; 89(3): 573 - 573.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Mellgren, G. Mellgren, S. Lundin, A. Wennmalm, and H. Wadenvik
Effect of Nitric Oxide Gas on Platelets During Open Heart Operations
Ann. Thorac. Surg., May 1, 1998; 65(5): 1335 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Heindl, S. Zahler, U. Welsch, and B. F Becker
Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts
Cardiovasc Res, May 1, 1998; 38(2): 383 - 394.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Endenburg, L. Lindeboom-Blokzijl, J. J. Zwaginga, J. J. Sixma, and P. G. de Groot
Plasma Fibrinogen Inhibits Platelet Adhesion in Flowing Blood to Immobilized Fibrinogen
Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 633 - 638.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1991 by American Society of Hematology         Online ISSN: 1528-0020